Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hamilton Robotics Builds Affymetrix’ CytoScan Automated Target Preparation Solution on Microlab NIMBUS

Published: Tuesday, January 22, 2013
Last Updated: Tuesday, January 22, 2013
Bookmark and Share
Customized Microlab NIMBUS 96 workstation helps speed clinical research with Affymetrix’ CytoScan Cytogenetics Solution.

Hamilton Robotics has announced that the soon-to-launch CytoScan Automated Target Preparation Solution from Affymetrix, Inc. is built on the customizable Microlab® NIMBUS 96 workstation from Hamilton Robotics. The Affymetrix NIMBUS Target Preparation Instrument automates target preparation for the CytoScan Cytogenetics Solution, which offers the broadest coverage and highest performance for detecting human chromosomal aberrations.

"Affymetrix chose to custom-design the NIMBUS workstation to automate sample preparation for its CytoScan Assay because the NIMBUS is a superior product at an affordable price compared to other liquid handling robots on the market. The exciting new system increases sample throughput at least two-fold for laboratories offering the CytoScan Solution for cytogenetic research applications while maintaining the same high performance," says Tanya Petrossian, Ph.D. Global Strategic Product Manager at Affymetrix.

"As an OEM partner, Hamilton Robotics was outstanding," continued Petrossian. "They worked side by side with us onsite during the early product development stage to ensure that the workstation was optimized to fit the requirements of the CytoScan Cytogenetics Solution workflow."

The Microlab NIMBUS96 is a customizable instrument platform that offers speed, ease of use, and superior pipetting performance in a small footprint for budget-conscious laboratories. The flexible system combines incredibly accurate liquid measurement with software that provides unprecedented workflow control, file handling, and integration with third-party devices. The compact, affordable system allows laboratories to process up to 96 samples at a time.
 
"Hamilton Robotics is thrilled to partner with Affymetrix to address the challenging requirements of cytogenetic researchers. Our workstations are easily adapted to even the most complex sample preparation needs of both the research environment and the rigid demands of regulated environments,” says Scott Eaton, Director of OEM and International Sales at Hamilton Robotics.

Hamilton Robotics tailor-made the Affymetrix NIMBUS for the CytoScan Assay using its rigorous custom-build process, which includes system definition, final design and system assembly, factory acceptance testing, and site acceptance testing.

“A custom-built Hamilton NIMBUS workstation offers superior quality for the same or lower price as other products on the market," says Jose Carle, Vice President at Hamilton Robotics. "Our experienced design teams, including application specialists, work closely with customers to ensure the final product perfectly matches the particular needs of the process."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Hamilton Robotics and French Police Scientifique Publish Paper Describing Large-Scale Production of Genetic Profiles
More than 300,000 profiles have already been processed on the Hamilton platforms and stored in French Database.
Wednesday, March 10, 2010
Automation of Adherent Cell Culture Maintenance
Hamilton, Life & Brain and University of Bonn will jointly develop a system for the automated culture of primary cells, cell lines and embryonic stem cells.
Monday, May 14, 2007
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!